Patients who choose not to intervene after a diagnosis of thyroid cancer face a challenging path—one that is often defined by a sense of isolation and anxiety, according to a first-of-its-kind study by researchers from ...
Mar 9, 2017
0
2
(HealthDay)—Many patients diagnosed with differentiated thyroid cancer perceive that they have no choice about receiving radioactive iodine (RAI), according to a study published online July 8 in the Journal of Clinical ...
Jul 15, 2019
0
1
The incidence of thyroid cancer in São Paulo State, part of Brazil's relatively developed Southeast region, varies considerably according to socioeconomic status (education, poverty, wealth, income, segregation, mobility, ...
Oct 31, 2023
0
0
(AP) -- A consumer advocacy group is calling on government regulators to withdraw a diabetes drug from Novo Nordisk, saying the injectable medication raises the risk of thyroid cancer, pancreatitis and kidney failure.
Apr 19, 2012
0
0
Anaplastic thyroid carcinoma (ATC) is an aggressive type of cancer with a poor prognosis for which there is currently no effective treatment. Researchers from the National University of Singapore (NUS) have discovered for ...
Feb 17, 2014
0
0
(HealthDay)—Poorer people are more likely than the rich to receive a thyroid cancer diagnosis after the disease has progressed to a more advanced stage, according to a new study.
Sep 20, 2012
0
0
Protein biomarkers are used to test for cancer before and after surgeries to remove tumors. To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research from Michigan Technological ...
Nov 12, 2015
0
14
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting ...
Jun 17, 2013
0
0
(Medical Xpress)—The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University ...
Apr 25, 2014
0
0
Vandetanib (trade name Caprelsa) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health ...
Nov 9, 2012
0
0
